Promoter analysis of human cholecystokinin type-A receptor gene

Journal of Gastroenterology

Volumn 37, Issue 10, 2002, Pages 815-820

  Takata, Yutaka ^a,b   Takeda, Shigeki ^c   Kawanami, Takako ^b   Takiguchi, Soichi ^a   Yoshida, Yuki ^d   Miyasaka, Kyoko ^d   Funakoshi, Akihiro ^b  

^a National Hospital Organization   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

CCK A receptor promoter; Polymorphism; STC 1 cells; Transcriptional activity

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CYTOSINE; GUANINE; LIGAND; PEPTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOCRINE TUMOR; GENE ACTIVITY; GENE CONSTRUCT; GENE DELETION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MOTIF; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CHOLECYSTOKININ; ENTEROENDOCRINE CELLS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; MICE; MICE, TRANSGENIC; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0036813463     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200135     Document Type: Article

References (26)

1. Presti ME, Gardner JD. Receptor antagonists for gastrointestinal peptides. Am J Physiol 1993;264:G399-406.
2. Wank SA. Cholecystokinin receptors. Am J Physiol 1995;269: G628-46.
3. Wank SA. G Protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family. Am J Physiol 1998;274:G607-13.
4. Zahidi A, Fourmy D, Darbon JM, Pradayrol L, Scemama JL, Ribet A. Molecular properties of solubilized CCK receptor from guinea-pig pancreas. Regul Pept 1986;5:25-36.
5. Pearson RK, Hadac EM, Miller LJ. Structural analysis of a distinct subtype of CCK receptor on human gastric smooth muscle tumors. Am J Physiol 1989;256:G1005-10.
6. Schjoldager B, Molero X, Miller LJ. Functional and biochemical characterization of the human gallbladder muscularis cholecystokinin receptor. Gastroenterology 1989;96:1119-25.
7. Schjoldager B, Molero X, Miller LJ. Gallbladder CCK receptors: species differences in glycosylation of similar protein cores. Regul Pept 1990;28:265-72.
8. Miller LJ. The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches. Yale J Biol Med 1992;65:441-8.
9. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 1992;89;3125-9.
10. de Weerth A, Pisegna JR, Huppi K, Wank SA. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Commun 1993;194:811-8.
11. Wank SA, Pisegna JR, de Weerth A. Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human. Ann N Y Acad Sci 1994;713:49-66.
12. Takata Y, Takiguchi S, Funakoshi A, Kono A. Gene structure of rat cholecystokinin type-A receptor. Biochem Biophys Res Commun 1995;213:958-66.
13. Takata Y, Takiguchi S, Kataoka K, Funakoshi A, Miyasaka K, Kono A. Mouse cholecystokinin type-A receptor gene and its structural analysis. Gene 1997;187:267-71.
14. Lacourse KA, Lay JM, Swanberg LJ, Jenkins C, Samuelson LC. Molecular structure of the mouse CCK-A receptor gene. Biochem Biophys Res Commun 1997;236:630-5.
15. Miller LJ, Holicky EL, Ulrich CD, Wieben ED. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 1995;109:1375-80.
16. Inoue H, Iannotti CA, Welling CM, Veile R, Donis-Keller H, Permutt MA. Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM). Genomics 1997;42:331-5.
17. Funakoshi A, Miyasaka K, Matsumoto H, Yamamori S, Takiguchi S, Kataoka K, et al. Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism. FEBS Lett 2000;466:264-6.
18. Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H. Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia. Am J Med Genet 2000;96:141-5.
19. Matsusue K, Takiguchi S, Takata Y, Funakoshi A, Miyasaka K, Kono A. Expression of cholecystokinin type A receptor gene correlates with DNA demethylation during postnatal development of rat pancreas. Biochem Biophys Res Commun 1999;264:29-32.
20. Rindi G, Grant SG, Yiangou Y, Ghatei MA, Bloom SR, Bautch VL, et al. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol 1990;136:1349-63.
21. Lu F, Jin T, Drucker DJ. Proglucagon gene expression is induced by gastrin-releasing peptide in a mouse enteroendocrine cell line. Endocrinology 1996;137:3710-6.
22. Boylan MO, Jepeal LI, Jarboe LA, Wolfe MM. Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene in a mouse neuroendocrine tumor cell line. J Biol Chem 1997;272:17438-43.
23. Deavall DG, Raychowdhury R, Dockray GJ, Dimaline R. Control of CCK gene transcription by PACAP in STC-1 cells. Am J Physiol 2000;279:G605-12.
24. Graff JR, Herman JG, Myohanen S, Baylin SB, Vertino PM. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997;272:22322-29.
25. Huang TH, Perry MR, Laux DE. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999;8:459-70.
26. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 2000;21:1761-5.